The Relation of Glucose Metabolism to Left Ventricular Mass and Function and Sympathetic Nervous System Activity in Obese Subjects With Metabolic Syndrome

Grants

Funding Acknowledgements

The study was funded by a Heart Foundation Grant-in-Aid (G11M5892) and a Diabetes Australia Millennium Grant to N.E.S. J.B.D., M.P.S., and G.W.L. are supported by NHMRC Fellowships. We also acknowledge the Victorian Government's Operational Infrastructure Support Program.N.E.S., M.T.G., C.I.S., S.K., C.W., N.E., K.L.R., G.L., and E.A.L. have nothing to declare. P.J.N. has consultative and advisory board associations with Merck Sharp & Dohme and Astra Zeneca. J.B.D. receives competitive research grant funding from Allergan Inc. He is a consultant for Allergan Inc., Bariatric Advantage, and Scientific Intake and is a member of the Optifast Medical Advisory Board for Nestle Health, Australia. He is on the speakers bureaus for Eli Lilly and iNova Pharmaceuticals, has developed educational material for Novartis and iNova Pharmaceuticals, and received travel assistance from GI Dynamics for an educational meeting. M.P.S. serves on scientific advisory boards for Abbott Pharmaceuticals, Novartis Pharmaceuticals, and Medtronic. G.W.L. has acted as a consultant for Medtronic and has received honoraria from Medtronic, Pfizer, and Wyeth Pharmaceuticals for presentations. These organizations played no role in the design, analysis, or interpretation of data described here or in the preparation, review, or approval of the manuscript.